Morgan E, Soerjomataram I, Rumgay H, et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology. 2022;163:649-58.e642.

Article  PubMed  Google Scholar 

Arnold M, Ferlay J, van Berge Henegouwen MI, Soerjomataram I. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut. 2020;69:1564–71.

Article  PubMed  Google Scholar 

Arnold M, Laversanne M, Brown LM, Devesa SS, Bray F. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. Am J Gastroenterol. 2017;112:1247–55.

Article  PubMed  Google Scholar 

Dubecz A, Solymosi N, Stadlhuber RJ, Schweigert M, Stein HJ, Peters JH. Does the incidence of adenocarcinoma of the esophagus and gastric cardia continue to rise in the twenty-first century? A SEER database analysis. J Gastrointest Surg. 2013;1:124–9.

Google Scholar 

Kusano C, Gotoda T, Khor CJ, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol. 2008;23:1662–5.

Article  PubMed  Google Scholar 

Matsuno K, Ishihara R, Ohmori M, et al. Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma. J Gastroenterol. 2019;54:784–91.

Article  PubMed  Google Scholar 

Qi J, Li M, Wang L, et al. National and subnational trends in cancer burden in China, 2005–20: an analysis of national mortality surveillance data. Lancet Public Health. 2023;8:e943–55.

Article  PubMed  Google Scholar 

Boerner T, Carr RA, Hsu M, et al. Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy. Int J Cancer. 2023;152:2109–22.

Article  PubMed  PubMed Central  Google Scholar 

Lee J, Lim DH, Kim S, et al. Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol. 2012;30:268–73.

Article  PubMed  Google Scholar 

Cats A, Jansen EPM, van Grieken NCT, et al. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. Lancet Oncol. 2018;19:616–28.

Article  PubMed  Google Scholar 

Vaidya JS, Bulsara M, Baum M, et al. Long-term survival and local control outcomes from single-dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT: a randomised clinical trial. BMJ. 2020;370:m2836.

Article  PubMed  PubMed Central  Google Scholar 

Gao P, Tsai C, Yang Y, et al. Intraoperative radiotherapy in gastric and esophageal cancer: meta-analysis of long-term outcomes and complications. Minerva Med. 2017;108:74–83.

Article  PubMed  Google Scholar 

Fu S, Lu JJ, Zhang Q, Yang Z, Peng L, Xiong F. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma. Int J Radiat Oncol Biol Phys. 2008;72:1488–94.

Article  PubMed  Google Scholar 

Cho Y, Kim JW, Kim HS, Park JS, Lee IJ. Intraoperative radiotherapy for resectable pancreatic cancer using a low-energy x-ray source: postoperative complications and early outcomes. Yonsei Med J. 2022;63:405–12.

Article  PubMed  PubMed Central  Google Scholar 

Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlations. Cancer. 1994;73:2680–6.

Article  PubMed  Google Scholar 

Low DE, Alderson D, Cecconello I, et al. International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg. 2015;262:286–94.

Article  PubMed  Google Scholar 

Krempien R, Roeder F. Intraoperative radiation therapy (IORT) in pancreatic cancer. Radiat Oncol. 2017;12:8.

Article  PubMed  PubMed Central  Google Scholar 

Valentini V, Calvo F, Reni M, et al. Intra-operative radiotherapy (IORT) in pancreatic cancer: joint analysis of the ISIORT-Europe experience. Radiother Oncol. 2009;91:54–9.

Article  PubMed  Google Scholar 

Skoropad VY, Berdov BA, Mardynski YS, Titova LN. A prospective, randomized trial of pre-operative and intraoperative radiotherapy versus surgery alone in resectable gastric cancer. Eur J Surg Oncol. 2000;26:773–9.

Article  PubMed  Google Scholar 

Tamaki Y, Sasaki R, Ejima Y, et al. Efficacy of intraoperative radiotherapy targeted to the abdominal lymph node area in patients with esophageal carcinoma. J Radiat Res. 2012;53:882–91.

Article  PubMed  PubMed Central  Google Scholar 

Calvo FA, Sole CV, Obregón R, et al. Postchemoradiation resected locally advanced esophageal and gastroesophageal junction carcinoma: long-term outcome with or without intraoperative radiotherapy. Ann Surg Oncol. 2013;20:1962–9.

Article  PubMed  Google Scholar 

Murakami M, Kuroda Y, Nakajima T, et al. Intraoperative radiotherapy for the abdominal lymphatic system in patients with esophageal carcinoma. Dis Esophagus. 1999;12:270–5.

Article  PubMed  Google Scholar 

Miller RC, Haddock MG, Gunderson LL, et al. Intraoperative radiotherapy for treatment of locally advanced and recurrent esophageal and gastric adenocarcinomas. Dis Esophagus. 2006;19:487–95.

Article  PubMed  Google Scholar 

Eyck BM, van Lanschot JJB, Hulshof M, et al. Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial. J Clin Oncol. 2021;39:1995–2004.

Article  PubMed  Google Scholar 

Yang H, Liu H, Chen Y, et al. Long-term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma: the NEOCRTEC5010 randomized clinical trial. JAMA Surg. 2021;156:721–9.

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Yang W, Wang Q, Zhou Y. Mechanisms of esophageal cancer metastasis and treatment progress. Front Immunol. 2023;14:1206504.

Article  PubMed  PubMed Central  Google Scholar 

Sun YF, Wu L, Liu SP, et al. Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma. Nat Commun. 2021;12:4091.

Article  PubMed  PubMed Central  Google Scholar 

Liu X, Song J, Zhang H, et al. Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance. Cancer Cell. 2023;41:272-7.e279.

Article  PubMed  Google Scholar 

Yang Y, Liu J, Liu Z, et al. Two-year outcomes of clinical N2–3 esophageal squamous cell carcinoma after neoadjuvant chemotherapy and immunotherapy from the phase 2 NICE study. J Thorac Cardiovasc Surg. 2024;167:838-47.e831.

Article  PubMed  Google Scholar 

Shitara K, Rha SY, Wyrwicz LS, et al. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study. Lancet Oncol. 2024;25:212–24.

Article  PubMed  Google Scholar